Visual Acuity, Oncologic, and Toxicity Outcomes With 103 Pd vs. 125 I Plaque Treatment for Choroidal Melanoma

Brachytherapy - United States
doi 10.1016/j.brachy.2017.01.012
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Visual Acuity, Contrast Sensitivity and Color Vision Three Years After Iodine-125 Brachytherapy for Choroidal and Ciliary Body Melanoma

Open Ophthalmology Journal
Ophthalmology
2015English

Commentary on Visual Acuity, Contrast Sensitivity and Color Vision Three Years After Iodine-125 Brachytherapy for Choroidal and Ciliary Body Melanoma

Journal of Clinical & Experimental Ophthalmology
2016English

Visual Acuity Outcomes of Ranibizumab Treatment in Pathologic Myopic Eyes With Macular Retinoschisis and Choroidal Neovascularization

Retina
MedicineOphthalmology
2017English

Visual Acuity in 3422 Consecutive Eyes With Choroidal Nevus

Archives of Ophthalmology
2007English

A Brief Editorial on Clinical Presentation and Treatment of Radiation Retinopathy Following Plaque Brachytherapy of Choroidal Melanoma

Journal of Clinical Research and Ophthalmology
2016English

Dosimetry of 125 I and 103 Pd COMS Eye Plaques for Intraocular Tumors: Report of Task Group 129 by the AAPM and ABS

Medical Physics
MedicineNuclear MedicineRadiologyImagingBiophysics
2012English

Erratum: New National Air-Kerma-Strength Standards for I-125 and Pd-103 Brachytherapy Seeds (Vol 108, No. 5, Pg 337, 2003)

Journal of Research of the National Institute of Standards and Technology
Engineering
2004English

Long-Term Visual Acuity, Strabismus, and Nystagmus Outcomes Following Multimodality Treatment in Group D Retinoblastoma Eyes

American Journal of Ophthalmology
Ophthalmology
2017English

Choroidal Melanoma and Pregnancy

Acta Ophthalmologica
MedicineOphthalmology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy